DeepMed Research

OCCLUTECH INTERNATIONAL AB

🇹🇭Thailand

Country: 🇹🇭Thailand

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases

Recruiting

Conditions: Muscular Ventricular Septal Defect

Interventions: Device: muscular ventricular septal defects

First Posted Date: 2022-04-15

Last Posted Date: 2024-02-14

Lead Sponsor: Occlutech International AB

Target Recruit Count: 100

Registration Number: NCT05329350

Locations: 🇹🇷
Gaziantep Unıversıty Hospital, Gaziantep, Şehitkamil, Turkey

PMCF Study to Evaluate Efficacy, Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects

Recruiting

Conditions: Patent Ductus Arteriosus

First Posted Date: 2022-03-03

Last Posted Date: 2023-06-18

Lead Sponsor: Occlutech International AB

Target Recruit Count: 255

Registration Number: NCT05264753

Locations: 🇵🇰
Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan
🇹🇳
Military Hospital, Tunis, Tunisia
🇮🇹
Ospedale Pediatrico Bambin Gesù, Roma, Italy

and more 5 locations

ACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices

Recruiting

Conditions: Heart Diseases

First Posted Date: 2021-12-30

Last Posted Date: 2023-08-14

Lead Sponsor: Occlutech International AB

Target Recruit Count: 385

Registration Number: NCT05174442

Locations: 🇩🇪
Uniklinik Erlangen, Erlangen, Germany
🇹🇷
Çukurova Üniversitesi Tıp Fakültesi Balcalı Hastanesi, Adana, Balcalı, Turkey
🇩🇪
Kliniken Maria Hilf GmbH, Mönchengladbach, Germany

and more 19 locations

Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study

Not Applicable

Active, not recruiting

Conditions: Heart Failure With Preserved Ejection Fraction (HFpEF)
Heart Failure With Reduced Ejection Fraction (HFrEF)

Interventions: Device: Atrial Flow Regulator
Device: Sham Comparator

First Posted Date: 2021-11-29

Last Posted Date: 2023-10-26

Lead Sponsor: Occlutech International AB

Target Recruit Count: 698

Registration Number: NCT05136820

Locations: 🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States
🇺🇸
Stony Brook Medicine, Stony Brook, New York, United States
🇺🇸
The Ohio State University Wexner Medical Center, Columbus, Ohio, United States

and more 22 locations

Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

Not Applicable

Active, not recruiting

Conditions: Stroke
Patent Foramen Ovale
PFO

Interventions: Device: Standard of Care PFO Closure Device
Device: Investigational PFO Closure Device

First Posted Date: 2021-10-06

Last Posted Date: 2025-02-26

Lead Sponsor: Occlutech International AB

Target Recruit Count: 450

Registration Number: NCT05069558

Locations: 🇩🇪
Universitätsklinik Heidelberg, Heidelberg, Germany
🇩🇪
Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Germany
🇩🇪
Asklepios Klinik Altona Hamburg, Hamburg, Germany

and more 45 locations

Occlutech Septal Occluder (Figulla Flex II) Study

Not Applicable

Completed

Conditions: Secundum Atrial Septal Defects

Interventions: Device: transcatheter closure of secundum atrial septal defects in patients

First Posted Date: 2020-07-27

Last Posted Date: 2020-07-27

Lead Sponsor: Occlutech International AB

Target Recruit Count: 175

Registration Number: NCT04488120

The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients

Recruiting

Conditions: Heart Failure

First Posted Date: 2020-05-28

Last Posted Date: 2024-07-17

Lead Sponsor: Occlutech International AB

Target Recruit Count: 150

Registration Number: NCT04405583

Locations: 🇩🇪
University Clinic Tübingen, Tübingen, Germany
🇫🇷
CHU Besançon, Besançon, France
🇩🇪
WKK Heide, Heide, Germany

and more 11 locations

A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® PmVSD Occluder in Patients With Perimembranous Ventricular Septal Defects

Active, not recruiting

Conditions: Perimembranous Ventricular Septal Defect

First Posted Date: 2019-07-26

Last Posted Date: 2024-02-15

Lead Sponsor: Occlutech International AB

Target Recruit Count: 50

Registration Number: NCT04034498

Locations: 🇩🇪
Ludwig Maximilians University, Munich, Germany
🇻🇳
City Children Hospital, Ho Chi Minh City, Vietnam
🇹🇭
Prince of Songkla University, Hat Yai, Thailand

and more 2 locations

The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO

Active, not recruiting

Conditions: PFO - Patent Foramen Ovale
Stroke

First Posted Date: 2019-07-23

Last Posted Date: 2023-10-18

Lead Sponsor: Occlutech International AB

Target Recruit Count: 570

Registration Number: NCT04029233

Locations: 🇩🇪
Herzzentrum Bremen, Bremen, Germany
🇩🇪
University Jena, Jena, Germany
🇫🇷
CHU Rangueil, Toulouse, France

and more 14 locations

The Prelieve Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients

Not Applicable

Completed

Conditions: Heart Failure Low Output
Heart Failure

Interventions: Device: Occlutech AFR device

First Posted Date: 2017-01-24

Last Posted Date: 2022-09-15

Lead Sponsor: Occlutech International AB

Target Recruit Count: 106

Registration Number: NCT03030274

Locations: 🇧🇪
University Hospital Brussels, Brussels, Laarbeeklaan 101, Belgium
🇧🇪
AZ Maria Middelares, Gent, Buitenring Sint-Denijs 30, Belgium
🇧🇪
UZ Leuven, Leuven, Herestraat 49, Belgium

and more 23 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy